Human Tissue (Transplantation, Post-Mortem, Anatomical Examination and Public Display) Act 2024

Consequential amendments to Regulations of 2012

37. (1) The Regulations of 2012 are amended—

(a) in Regulation 2, by the insertion of the following definitions:

“ ‘Act of 2024’ means the Human Tissue (Transplantation, Post-Mortem, Anatomical Examination and Public Display) Act 2024;

‘relevant provisions of Part 2 of the Act of 2024’ means the provisions concerning transplantation activities relating to organs with respect to which the Authority is required to monitor compliance pursuant to section 35 of the Act of 2024;”,

(b) in Regulation 4, by the substitution in paragraph (7), of—

(i) “the Directive, these Regulations and section 35 of the Act of 2024” for “the Directive and these Regulations”, and

(ii) “section 4(1)(x)” for “section 4(1)(v)”,

(c) in Regulation 5, by the substitution in paragraph (1), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(d) in Regulation 6—

(i) by the substitution in paragraph (1), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”, and

(ii) by the substitution in paragraph (4)(a), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(e) in Regulation 8, by the substitution of the following paragraph for paragraph (3)(a):

“(a) the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024, or”,

(f) in Regulation 9, by the substitution, in paragraph (1)(a), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(g) in Regulation 10—

(i) by the substitution, in paragraph (1)(a), of “the Directive, these Regulations, the relevant provisions of Part 2 of the Act of 2024” for “these Regulations, the Directive”, and

(ii) by the substitution, in paragraph (2)(a), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directives”,

(h) in Regulation 11, by the substitution in paragraph (2)(a), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “the Directive and these Regulations”,

(i) in Regulation 12, by the substitution, in paragraph (1), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(j) in paragraph (3) of Regulation 15—

(i) by the substitution of “laid down in the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “laid down in these Regulations and the Directive”, and

(ii) by the deletion, in subparagraph (a), of “and provide him or her with the information he or she needs to understand the consequences of donation,”,

(k) by the deletion of Regulations 21 and 22,

(l) in Regulation 23, by the substitution, in paragraph (1), of the following subparagraph for subparagraph (b):

“(b) ensure that living donors are selected on the basis of their health and medical history, by suitably qualified or trained and competent professionals and in accordance with the relevant provisions of Part 2 of the Act of 2024,”,

(m) in Regulation 24, by the substitution—

(i) in paragraph (1)(b), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”, and

(ii) in paragraph (2), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(n) in Regulation 26, by the substitution in paragraph (1), of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “these Regulations and the Directive”,

(o) in Regulation 31, by the substitution of “the Directive, these Regulations and the relevant provisions of Part 2 of the Act of 2024” for “the Directive and these Regulations” in each place where it occurs,

(p) in Regulation 32—

(i) in paragraph (1)—

(I) by the substitution of “Chief Executive of the Health Products Regulatory Authority” for “IMB” in each place where it occurs, and

(II) by the substitution of “her or him” for “it”,

and

(ii) by the substitution of “these Regulations or the relevant provisions of Part 2 of the Act of 2024” for “these Regulations” in each place where it occurs,

(q) in Regulation 34, by the substitution of “these Regulations or the relevant provisions of Part 2 of the Act of 2024” for “these Regulations” where it firstly occurs,

(r) in Regulation 35—

(i) by the deletion, in paragraph (1), of “20, 21(1), (2) or (4)”, and

(ii) in paragraph (2)—

(I) by the substitution of “a person who” for “a person”,

(II) by the deletion, in subparagraph (a), of “who”,

(III) by the deletion of subparagraph (i),

(IV) by the substitution of the following subparagraph for subparagraph (j):

“(j) harbours, imports or exports an organ contrary to these Regulations and the Directive, or”,

and

(V) by the deletion, in paragraph (k) of “who”,

and

(s) in the Schedule, by the substitution of “Regulations 2012 and the relevant provisions of Part 2 of the Act of 2024” for “Regulations 2012” in each place where it occurs.